Core Viewpoint - Leapfrog Acquisition Corporation has announced the pricing of its initial public offering (IPO) of 12,500,000 units at a price of $10.00 per unit, with trading expected to commence on December 5, 2025, on the Nasdaq Stock Market under the symbol LFACU [1] Company Overview - Leapfrog Acquisition Corporation is a special purpose acquisition company (SPAC) formed to engage in mergers, amalgamations, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses [2][7] - The company is led by Matthew R. Pollard (CEO), Abhay N. Pande (President and Chief Investment Officer), and Kevin M. Murphy (Chief Financial Officer) [2][7] IPO Details - Each unit sold in the offering consists of one Class A ordinary share and one half of one redeemable warrant with a strike price of $11.50 per ordinary share, exercisable within 5 years of completing an initial business combination [3] - The offering is managed by BTIG, LLC, which has been granted a 45-day option to purchase up to an additional 1,875,000 units at the IPO price to cover overallotments [4] Business Focus - The company will prioritize businesses in the international energy supply chain and critical minerals sectors, including related infrastructure, in its search for attractive merger candidates [8]

Company Overview - Tarkett is a global leader in innovative and sustainable flooring and sports surface solutions, with a history spanning over 140 years [2] - The company generated a turnover of €3.3 billion in 2024 and employs nearly 12,000 people [2] - Tarkett operates 24 R&D centers, 8 recycling centers, and 35 production sites, serving customers in over 100 countries [2] Voting Rights and Shares - As of November 30, 2025, Tarkett's total number of shares in the share capital is 65,550,281 [1] - The total number of voting rights is reported as 123,579,938, with 123,920,020 exercisable voting rights after deducting treasury shares without voting rights [1]

Core Insights - Temenos has been awarded the title of Best Core Banking System in the Banking Tech Awards 2025, highlighting its global banking capabilities and innovation [1][2] - This recognition follows an earlier win in the same category at the Banking Tech Awards USA earlier in the year, showcasing Temenos' strong market position and customer success [2] Company Performance - Temenos is trusted by over 950 banks worldwide for core banking solutions, offering flexibility and a path to modernization through cloud-native architecture [3] - The company invests approximately 20% of its annual revenues in research and development, enhancing its core capabilities across various deployment methods [4] Innovations and Developments - Recent innovations include a Gen AI Copilot designed to expedite the design, launch, testing, and optimization of financial products, and an FCM AI Agent aimed at reducing false positives in sanctions screening [4] - Temenos has received multiple accolades this year, including being named the best-selling core banking provider for 20 consecutive years in the IBS Intelligence Sales League Table 2025 and recognized as the Best Core Banking Solution by Euromoney [5]

Core Viewpoint - Heineken N.V. has appointed Alex Carreteiro as Regional President Americas, effective March 1, 2026, succeeding Marc Busain, who left the company on October 1, 2025 [1][5]. Group 1: Appointment Details - Alex Carreteiro joins Heineken from PepsiCo, where he was the CEO of PepsiCo Brazil & South Cone Foods, overseeing 16,000 employees and 10 factories across multiple countries [2]. - Under Carreteiro's leadership, PepsiCo's Brazil business doubled in size and was recognized as PepsiCo's Global Business Unit of the Year in 2024 [2]. Group 2: Professional Background - Carreteiro has nearly two decades of experience at Nestlé, holding senior roles in General Management, Sales, and Finance across Europe and the Americas [3]. - His last position at Nestlé was Vice President of North America, and he also served as CEO of the Latin Caribbean region and Managing Director of Nestlé Waters Brazil and Portugal [3]. Group 3: Expertise and Leadership Style - Carreteiro brings extensive expertise in beverages and food, with a strong track record in M&A and post-merger integration [4]. - He is known for building high-performing, diverse teams and has demonstrated commercial excellence by establishing trust-based relationships with trade partners [4]. Group 4: Strategic Importance - Dolf van den Brink, CEO and Chairman of the Executive Board, emphasized that Carreteiro's appointment aligns with Heineken's ambition to accelerate growth and transformation in the Americas, which is critical to the company's long-term EverGreen strategy [5].

Core Viewpoint - Volta Finance Limited successfully passed all resolutions at its Annual General Meeting, including a special resolution, indicating strong governance and shareholder support [2][3]. Company Overview - Volta Finance Limited is incorporated in Guernsey and listed on Euronext Amsterdam and the London Stock Exchange, subject to regulation by the AFM in the Netherlands [4][5]. - The company aims to preserve capital across the credit cycle and provide stable income through quarterly dividends, primarily investing in CLOs and similar asset classes [5]. Investment Management - AXA Investment Managers Paris is appointed as the investment manager for Volta Finance, specializing in structured credit [5][6]. - AXA IM is a significant player in the asset management industry, managing over €879 billion in assets as of June 2025 [6].

Core Points - Sampo plc has initiated a share buyback program with a maximum value of EUR 150 million, which commenced on 6 November 2025 [1][2] - On 4 December 2025, Sampo plc acquired a total of 270,007 A shares at an average price of EUR 9.95 per share [1] - Following the transactions, Sampo plc now holds a total of 5,079,610 A shares, representing 0.19% of the total shares outstanding [2] Summary by Sections Share Buyback Program - The share buyback program was announced on 5 November 2025 and is in compliance with the Market Abuse Regulation (EU) 596/2014 [1] - The program is based on the authorization granted by Sampo's Annual General Meeting on 23 April 2025 [1] Transaction Details - The breakdown of shares acquired on 4 December 2025 includes: - 3,725 shares on AQEU - 112,873 shares on CEUX - 24,983 shares on TQEX - 128,426 shares on XHEL - The total volume of shares bought back on that day was 270,007 [1] Ownership Post-Transaction - After the buybacks, Sampo plc's total ownership of A shares is 5,079,610, which constitutes 0.19% of the total shares [2]

Core Insights - ORIC Pharmaceuticals announced data from a Phase 1b trial of enozertinib (ORIC-114) for treating NSCLC patients with HER2 exon 20 mutations, showing a 35% overall response rate (ORR) and 100% disease control rate (DCR) in the 80 mg cohort [1][8] - The trial included patients with active brain metastases, and the safety profile was manageable with a low discontinuation rate due to treatment-related adverse events (TRAEs) [1][4] - Enrollment for the HER2 exon 20 patient population has been completed, with no further development planned, while the 80 mg dose has been selected for potential Phase 3 development based on preliminary data [6][8] Trial Design and Patient Demographics - The Phase 1b trial evaluated enozertinib in patients with locally advanced or metastatic NSCLC with HER2 exon 20 mutations, allowing for patients with untreated brain metastases [2] - As of the cutoff date, 49 patients were dosed, with 80% having received prior chemotherapy and 35% having undergone HER2 targeted therapy [3] Safety and Efficacy Analysis - Enozertinib was well tolerated, with most TRAEs being Grade 1 or 2, and only 2 patients discontinued treatment due to TRAEs [4] - Tumor responses were noted in both dosing cohorts, with deeper regressions observed in the 80 mg cohort, potentially due to fewer dose reductions [5] Next Steps and Future Development - The company plans to continue enrollment and follow-up in 1L NSCLC patients with EGFR exon 20 and other mutations, with updates expected in mid-2026 [6] - The 80 mg QD oral enozertinib has been selected for potential Phase 3 development based on the trial results [6] Conference Call and Webcast - ORIC will host a conference call and webcast on December 6, 2025, to discuss the trial results and future plans [7]

Core Points - AS Tallinna Sadam plans to disclose its financial results and hold its annual general meeting according to a specific schedule in 2026 [1] - The company is one of the largest cargo and passenger port complexes in the Baltic Sea region, providing various services including ferry operations and shipping [2] Schedule of Financial Disclosures - The unaudited interim report for 2025 will be released on February 26, 2026 [1] - The audited annual report for 2025 and dividend proposal will be disclosed on April 2, 2026 [1] - The annual general meeting of shareholders is scheduled for April 28, 2026 [1] - Additional interim reports for Q1, Q2, and Q3 of 2026 will be published throughout the year [1] Company Operations - Tallinna Sadam operates ferry services between the Estonian mainland and its largest islands through its subsidiary OÜ TS Laevad [2] - The company also engages in shipping activities via its subsidiary OÜ TS Shipping, which charters the multifunctional vessel Botnica for icebreaking and offshore services [2] - Tallinna Sadam is a shareholder in AS Green Marine, which provides waste management services [2]

Core Viewpoint - Bigben Interactive is initiating discussions with holders of senior conditionally secured bonds exchangeable into Nacon company shares, maturing on February 19, 2026, to renegotiate the terms of the bonds to maintain operational and financial flexibility [1][6]. Group 1: Bond Details - The company established a bond loan amounting to €87.3 million on February 12, 2021, with a maturity date of February 19, 2026 [2]. - As of the press release date, the outstanding amount of the bonds totals €57.4 million, which is repayable at maturity at 103%, equating to €59.1 million [3]. - After a partial refinancing agreement of €43 million secured on November 24, 2025, the residual unrefinanced balance of the bonds is approximately €16 million [4][5]. Group 2: Strategic Intentions - The company aims to propose a renegotiation of the bond terms to avoid premature cash mobilization that could limit development prospects [6]. - Following discussions, all bondholders may be convened to vote on any amendments to the bond terms in accordance with legal and regulatory provisions [7]. Group 3: Company Overview - Bigben Interactive is a European player in video game publishing and the design and distribution of mobile and gaming accessories, as well as audio-video products, with a goal to be a leader in its markets [8]. - The company is listed on Euronext Paris and has over 1,300 employees [8].

Core Viewpoint - Ipsen is undergoing a transfer of shares from Beech Tree to the Alasol Foundation, following the wishes of the late Mr. Henri Beaufour, a board member and representative of the founding family [1][2]. Group 1: Share Transfer Details - Beech Tree is the holding company that owns Mr. Beaufour's stake in Ipsen [2]. - The Alasol Foundation, created by Mr. Beaufour, focuses on promoting education and vocational training for disadvantaged children and young adults [2]. - The share transfer is expected to occur in early 2026, pending regulatory approvals [1]. Group 2: Company Overview - Ipsen is a global biopharmaceutical company specializing in transformative medicines across three therapeutic areas: Oncology, Rare Disease, and Neuroscience [3]. - The company has nearly 100 years of development experience and operates global hubs in the U.S., France, and the U.K., with teams in over 40 countries [3]. - Ipsen's medicines reach patients in more than 100 countries, supported by both internal and external innovation [3]. Group 3: Stock Information - Ipsen is listed on Euronext Paris under the ticker IPN and has a Sponsored Level I American Depositary Receipt program in the U.S. under the ticker IPSEY [4].